204 related articles for article (PubMed ID: 24870262)
1. Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer.
Kim TM; Jung SH; Baek IP; Lee SH; Choi YJ; Lee JY; Chung YJ; Lee SH
J Pathol; 2014 Aug; 233(4):425-35. PubMed ID: 24870262
[TBL] [Abstract][Full Text] [Related]
2. Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins.
Lindberg J; Klevebring D; Liu W; Neiman M; Xu J; Wiklund P; Wiklund F; Mills IG; Egevad L; Grönberg H
Eur Urol; 2013 Feb; 63(2):347-53. PubMed ID: 22502944
[TBL] [Abstract][Full Text] [Related]
3. Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling.
Choi YJ; Rhee JK; Hur SY; Kim MS; Lee SH; Chung YJ; Kim TM; Lee SH
J Pathol; 2017 Jan; 241(1):57-66. PubMed ID: 27741368
[TBL] [Abstract][Full Text] [Related]
4. Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.
Linch M; Goh G; Hiley C; Shanmugabavan Y; McGranahan N; Rowan A; Wong YNS; King H; Furness A; Freeman A; Linares J; Akarca A; Herrero J; Rosenthal R; Harder N; Schmidt G; Wilson GA; Birkbak NJ; Mitter R; Dentro S; Cathcart P; Arya M; Johnston E; Scott R; Hung M; Emberton M; Attard G; Szallasi Z; Punwani S; Quezada SA; Marafioti T; Gerlinger M; Ahmed HU; Swanton C
Ann Oncol; 2017 Oct; 28(10):2472-2480. PubMed ID: 28961847
[TBL] [Abstract][Full Text] [Related]
5. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
[TBL] [Abstract][Full Text] [Related]
6. Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary.
Tothill RW; Li J; Mileshkin L; Doig K; Siganakis T; Cowin P; Fellowes A; Semple T; Fox S; Byron K; Kowalczyk A; Thomas D; Schofield P; Bowtell DD
J Pathol; 2013 Dec; 231(4):413-23. PubMed ID: 24037760
[TBL] [Abstract][Full Text] [Related]
7. Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genes.
Luedeke M; Linnert CM; Hofer MD; Surowy HM; Rinckleb AE; Hoegel J; Kuefer R; Rubin MA; Vogel W; Maier C
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3030-5. PubMed ID: 19861517
[TBL] [Abstract][Full Text] [Related]
8. Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.
Løvf M; Zhao S; Axcrona U; Johannessen B; Bakken AC; Carm KT; Hoff AM; Myklebost O; Meza-Zepeda LA; Lie AK; Axcrona K; Lothe RA; Skotheim RI
Eur Urol; 2019 Mar; 75(3):498-505. PubMed ID: 30181068
[TBL] [Abstract][Full Text] [Related]
9. Screening of genetic and expression alterations of SRC1 gene in prostate cancer.
Mäki HE; Waltering KK; Wallén MJ; Martikainen PM; Tammela TL; van Weerden WM; Vessella RL; Visakorpi T
Prostate; 2006 Sep; 66(13):1391-8. PubMed ID: 16894533
[TBL] [Abstract][Full Text] [Related]
10. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines.
Zhao H; Kim Y; Wang P; Lapointe J; Tibshirani R; Pollack JR; Brooks JD
Prostate; 2005 May; 63(2):187-97. PubMed ID: 15486987
[TBL] [Abstract][Full Text] [Related]
12. The mitochondrial and autosomal mutation landscapes of prostate cancer.
Lindberg J; Mills IG; Klevebring D; Liu W; Neiman M; Xu J; Wikström P; Wiklund P; Wiklund F; Egevad L; Grönberg H
Eur Urol; 2013 Apr; 63(4):702-8. PubMed ID: 23265383
[TBL] [Abstract][Full Text] [Related]
13. Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer.
Kristiansen A; Bergström R; Delahunt B; Samaratunga H; Guðjónsdóttir J; Grönberg H; Egevad L; Lindberg J
Prostate; 2019 Jun; 79(8):920-928. PubMed ID: 30908670
[TBL] [Abstract][Full Text] [Related]
14. Many private mutations originate from the first few divisions of a human colorectal adenoma.
Kang H; Salomon MP; Sottoriva A; Zhao J; Toy M; Press MF; Curtis C; Marjoram P; Siegmund K; Shibata D
J Pathol; 2015 Nov; 237(3):355-62. PubMed ID: 26119426
[TBL] [Abstract][Full Text] [Related]
15. Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis.
Robert G; Jannink S; Smit F; Aalders T; Hessels D; Cremers R; Mulders PF; Schalken JA
Prostate; 2013 Jan; 73(2):113-20. PubMed ID: 22674214
[TBL] [Abstract][Full Text] [Related]
16. Identification of frequent BRAF copy number gain and alterations of RAF genes in Chinese prostate cancer.
Ren G; Liu X; Mao X; Zhang Y; Stankiewicz E; Hylands L; Song R; Berney DM; Clark J; Cooper C; Lu YJ
Genes Chromosomes Cancer; 2012 Nov; 51(11):1014-23. PubMed ID: 22833462
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
[TBL] [Abstract][Full Text] [Related]
18. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer.
Suzuki Y; Ng SB; Chua C; Leow WQ; Chng J; Liu SY; Ramnarayanan K; Gan A; Ho DL; Ten R; Su Y; Lezhava A; Lai JH; Koh D; Lim KH; Tan P; Rozen SG; Tan IB
Mol Oncol; 2017 Feb; 11(2):124-139. PubMed ID: 28145097
[TBL] [Abstract][Full Text] [Related]
19. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.
Andor N; Graham TA; Jansen M; Xia LC; Aktipis CA; Petritsch C; Ji HP; Maley CC
Nat Med; 2016 Jan; 22(1):105-13. PubMed ID: 26618723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
